Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

Biopharma AS

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 28,278 Less Arrow 24,311 More Arrow 26,646
Financial expenses 26 Less Arrow 0 Equal arrow 0
Earnings before taxes 6,121 Less Arrow 3,749 Less Arrow 873
Total assets 18,021 Less Arrow 11,249 More Arrow 16,293
Current assets 18,021 Less Arrow 11,249 More Arrow 16,293
Current liabilities 11,294 Less Arrow 4,572 More Arrow 12,268
Equity capital 5,851 Less Arrow 5,582 Less Arrow 2,658
- share capital 30 Equal arrow 30 Equal arrow 30

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 32.5% More Arrow 49.6% Less Arrow 16.3%
Turnover per employee
Profit as a percentage of turnover 21.6% Less Arrow 15.4% Less Arrow 3.3%
Return on assets (ROA) 34.1% Less Arrow 33.3% Less Arrow 5.4%
Current ratio 159.6% More Arrow 246.0% Less Arrow 132.8%
Return on equity (ROE) 104.6% Less Arrow 67.2% Less Arrow 32.8%
Change turnover 3,967 Less Arrow -2,335 More Arrow 515
Change turnover % 16% Less Arrow -9% More Arrow 2%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.